These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28976412)

  • 21. Levetiracetam for people with mental retardation and refractory epilepsy.
    Kelly K; Stephen LJ; Brodie MJ
    Epilepsy Behav; 2004 Dec; 5(6):878-83. PubMed ID: 15582836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-life experience with brivaracetam in 101 patients with difficult-to-treat epilepsy-A monocenter survey.
    Steinhoff BJ; Bacher M; Bucurenciu I; Hillenbrand B; Intravooth T; Kornmeier R; Kurth C; Stockinger J; Staack AM
    Seizure; 2017 May; 48():11-14. PubMed ID: 28364655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Saliva and serum levetiracetam concentrations in patients with epilepsy.
    Mecarelli O; Li Voti P; Pro S; Romolo FS; Rotolo M; Pulitano P; Accornero N; Vanacore N
    Ther Drug Monit; 2007 Jun; 29(3):313-8. PubMed ID: 17529888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of levetiracetam use following resective surgery in patients with refractory epilepsy: a prospective observational study.
    Zeng TF; Li YH; An DM; Chen L; Lei D; Zhang B; Li JM; Zhou D
    Epilepsy Res; 2014 Dec; 108(10):1904-11. PubMed ID: 25454502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Levetiracetam (keppra) in the treatment of different epileptic syndromes in adults].
    Rudakova IG; Kotov AS; Kotov SV; Belova IuA; Lavrent'eva NS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(10):25-9. PubMed ID: 20037566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolerability and efficacy of oral loading of levetiracetam.
    Koubeissi MZ; Amina S; Pita I; Bergey GK; Werz MA
    Neurology; 2008 May; 70(22 Pt 2):2166-70. PubMed ID: 18505995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum concentration/dose ratio of levetiracetam before, during and after pregnancy.
    Westin AA; Reimers A; Helde G; Nakken KO; Brodtkorb E
    Seizure; 2008 Mar; 17(2):192-8. PubMed ID: 18180176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between efficacy of levetiracetam and serum levels among children with refractory epilepsy.
    Sheinberg R; Heyman E; Dagan Z; Youngster I; Kohn E; Gandelman-Marton R; Berkovitch M
    Pediatr Neurol; 2015 Jun; 52(6):624-8. PubMed ID: 25791893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levetiracetam clinical pharmacokinetics in elderly and very elderly patients with epilepsy.
    Contin M; Mohamed S; Albani F; Riva R; Baruzzi A
    Epilepsy Res; 2012 Feb; 98(2-3):130-4. PubMed ID: 21944894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of serum levetiracetam concentrations on therapeutic response and IL1-beta concentration in patients with epilepsy.
    Gulcebi MI; Kendirli T; Turgan ZA; Patsalos PN; Onat Yilmaz F
    Epilepsy Res; 2018 Dec; 148():17-22. PubMed ID: 30326332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of the initial efficacy of levetiracetam in patients with refractory epilepsy.
    Lee GH; Kim BM; Kang JK; Lee SA
    Seizure; 2013 Apr; 22(3):185-8. PubMed ID: 23280273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA).
    Stefan H; Wang-Tilz Y; Pauli E; Dennhöfer S; Genow A; Kerling F; Lorber B; Fraunberger B; Halboni P; Koebnick C; Gefeller O; Tilz C
    Epilepsia; 2006 Mar; 47(3):516-22. PubMed ID: 16529615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levetiracetam in patients with refractory epilepsy: results of the SKATE trial in Austria, Germany and Switzerland.
    Steinhoff BJ; Trinka E; Wieser HG;
    Seizure; 2005 Oct; 14(7):490-6. PubMed ID: 16169256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical predictors in patients with refractory epilepsy exposed to levetiracetam: a single-center study.
    Peltola J; Peltola M; Auvinen A; Keränen T; Liimatainen S; Kharazmi E; Fallah M
    Acta Neurol Scand; 2008 May; 117(5):332-6. PubMed ID: 18081915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levetiracetam in patients with epilepsy and chronic liver disease: observations in a case series.
    Bilo L; Meo R; de Leva MF; De Simone R; Di Nocera P; Pisani F; Striano S
    Clin Neuropharmacol; 2008; 31(4):221-5. PubMed ID: 18670245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term Effectiveness of Antiepileptic Drug Monotherapy in Partial Epileptic Patients: A 7-year Study in an Epilepsy Center in China.
    Zhu F; Lang SY; Wang XQ; Shi XB; Ma YF; Zhang X; Chen YN; Zhang JT
    Chin Med J (Engl); 2015 Nov; 128(22):3015-22. PubMed ID: 26608980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Levetiracetam in the treatment of epilepsy in adults. Experience with monotherapy].
    Molins A; Villanueva VE
    Rev Neurol; 2007 Sep 16-30; 45(6):331-3. PubMed ID: 17899513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy.
    Grosso S; Cordelli DM; Franzoni E; Coppola G; Capovilla G; Zamponi N; Verrotti A; Morgese G; Balestri P
    Seizure; 2007 Jun; 16(4):345-50. PubMed ID: 17368928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of age and comedication on levetiracetam pharmacokinetics and tolerability.
    Hirsch LJ; Arif H; Buchsbaum R; Weintraub D; Lee J; Chang JT; Resor SR; Bazil CW
    Epilepsia; 2007 Jul; 48(7):1351-9. PubMed ID: 17573925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.